How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports
About this episode
The episode discusses the effectiveness of GLP-1 agonists in reducing weight and cancer risk in individuals with obesity.
For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers. Kimmel Cancer Center director … How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports Read More »
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- Several strategies seem to help in keeping mosquitoes out of your yard, Elizabeth Tracey reports
- Keeping your backyard barbecue free of mosquitoes is possible, Elizabeth Tracey reports
- How often can a blood test predict cancer risk? Elizabeth Tracey reports
- Will a blood test compel more people to be screened for lung cancer? Elizabeth Tracey reports
- Can a blood test improve lung cancer screening? Elizabeth Tracey reports
- What do false positives and negatives have to do with screening tests for cancer? Elizabeth Tracey reports
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.